aspartic acid has been researched along with Cystic Fibrosis of Pancreas in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barros-Angueira, F; Colon-Mejeras, C; Couce, ML; Fernández-Lorenzo, AE; Leis, R; Moreno-Álvarez, A; Sirvent-Gómez, J; Solar-Boga, A | 1 |
| Cesaro, L; Donella-Deana, A; Marin, O; Pinna, LA; Venerando, A | 1 |
| Becq, F; Bilan, F; Kitzis, A; Melin, P; Norez, C; Thoreau, V | 1 |
| Cameran, M; Olante, P; Picci, L; Scarpa, M; Zacchello, F | 1 |
| Ahadizadeh, A; Costelloe, EA; Delaney, SJ; Geczy, CL; Hume, DA; Lunn, DP; McGlinn, EC; McMorran, BJ; Passey, R; Stacey, KJ; Thomas, GR; Wainwright, BJ | 1 |
| Ambrosioni, A; Bassotti, A; Corbetta, C; Fiori, S; Giunta, A; Padoan, R; Prandoni, S; Rajnoldi, AC; Seia, M | 1 |
| Brock, DJ; Corey, M; Durie, P; Hamosh, A; Keston, M; King, TM; Levison, H; McIntosh, I; Rosenstein, BJ; Tsui, LC | 1 |
7 other study(ies) available for aspartic acid and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
V232D mutation in patients with cystic fibrosis: Not so rare, not so mild.
Topics: Adult; Aged; Amino Acid Substitution; Aspartic Acid; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mutation; Neonatal Screening; Valine | 2018 |
A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.
Topics: Amino Acid Sequence; Aspartic Acid; Casein Kinase II; Consensus Sequence; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dictyostelium; Glutamic Acid; Humans; Molecular Sequence Data; Phosphorylation; Protein Interaction Domains and Motifs; Serine; Tyrosine | 2014 |
The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein.
Topics: Amino Acid Motifs; Animals; Aspartic Acid; COS Cells; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genistein; Glycine; Humans; Mutation; Transfection | 2004 |
Identification of a D579G homozygote cystic fibrosis patient with pancreatic sufficiency and minor lung involvement. Mutations in brief no. 221. Online.
Topics: Adult; Amino Acid Substitution; Aspartic Acid; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Glycine; Homozygote; Humans; Lung | 1999 |
G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Biomarkers; Bone Marrow Cells; Cell Movement; Cystic Fibrosis; Disease Models, Animal; Glycine; Inflammation; Injections, Intravenous; Lipopolysaccharides; Lung; Macrophages; Mice; Mice, Mutant Strains; Mutation, Missense; Neutrophils; RNA, Messenger | 2000 |
A novel missense mutation (D110E) in exon 4 of CFTR (ABCC7) in a CF infant presenting with hypochloraemic metabolic alkalosis.
Topics: Alkalosis; Amino Acid Substitution; Aspartic Acid; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Glutamic Acid; Humans; Infant; Infant, Newborn; Male; Mutation, Missense | 2000 |
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.
Topics: Adolescent; Aspartic Acid; Child; Child, Preschool; Codon; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Glycine; Homozygote; Humans; Infant, Newborn; Intestinal Obstruction; Meconium; Membrane Proteins; Mutation; Risk Factors | 1992 |